Beijing Balance Medical Technology Co.,Ltd. Share Price
Equities
688198
CNE100005X15
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.00 CNY | -2.65% |
|
+0.88% | +5.60% |
| Capitalization | 1.56TCr 223.38Cr 192.58Cr 179.28Cr 166.9Cr 310.75Cr 20TCr 334.34Cr 2.06TCr 813.14Cr 9.67TCr 837.71Cr 820.46Cr 35TCr | P/E ratio 2025 * |
83.1x | P/E ratio 2026 * | 57.1x |
|---|---|---|---|---|---|
| Enterprise value | 1.56TCr 223.38Cr 192.58Cr 179.28Cr 166.9Cr 310.75Cr 20TCr 334.34Cr 2.06TCr 813.14Cr 9.67TCr 837.71Cr 820.46Cr 35TCr | EV / Sales 2025 * |
22.8x | EV / Sales 2026 * | 16.9x |
| Free-Float |
26.33% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -2.65% | ||
| 1 week | +0.88% | ||
| Current month | +5.60% | ||
| 1 month | -1.39% | ||
| 3 months | +3.67% | ||
| 6 months | +9.73% | ||
| Current year | +5.60% |
| 1 week | 111 |  | 116.8 |
| 1 month | 105 | | 116.8 |
| Current year | 106.01 | | 116.8 |
| 1 year | 95.28 | | 132.94 |
| 3 years | 92.55 | | 166 |
| 5 years | 61.32 | | 235.71 |
| 10 years | 22.14 | | 235.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Jin
CEO | Chief Executive Officer | 72 | 11/07/2005 |
Qi Cheng
DFI | Director of Finance/CFO | 58 | 01/07/2017 |
Jia Wu
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Yan Fang Li
BRD | Director/Board Member | 62 | 01/02/2018 |
Li Yan Li
BRD | Director/Board Member | 46 | 11/07/2005 |
Sen Jin
BRD | Director/Board Member | 66 | 01/05/2005 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.65% | +0.88% | +2.62% | -14.97% | 223.38Cr | |
| +0.36% | -1.02% | -5.12% | +41.88% | 14TCr | |
| -0.16% | -1.75% | +20.53% | +8.42% | 1.41TCr | |
| +5.03% | +6.48% | -23.12% | +144.84% | 690.26Cr | |
| -1.68% | -2.40% | -15.58% | -67.45% | 632.91Cr | |
| +0.75% | -.--% | -.--% | +5.41% | 362.77Cr | |
| -1.14% | -1.74% | +41.89% | +36.28% | 293.52Cr | |
| -4.40% | -6.25% | -48.09% | -63.92% | 267.99Cr | |
| Average | -0.49% | -0.75% | -3.36% | +11.31% | 2.22TCr | |
| Weighted average by Cap. | +0.30% | -0.90% | -3.84% | +36.20% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 68Cr 9.79Cr 8.44Cr 7.85Cr 7.31Cr 14Cr 888.05Cr 15Cr 90Cr 36Cr 423.6Cr 37Cr 36Cr 1.55TCr | 92Cr 13Cr 11Cr 11Cr 9.88Cr 18Cr 1.2TCr 20Cr 122.02Cr 48Cr 572.04Cr 50Cr 49Cr 2.09TCr |
| Net income | 19Cr 2.68Cr 2.31Cr 2.15Cr 2.01Cr 3.73Cr 243.5Cr 4.02Cr 25Cr 9.77Cr 116.15Cr 10Cr 9.86Cr 424.11Cr | 27Cr 3.92Cr 3.38Cr 3.14Cr 2.93Cr 5.45Cr 355.48Cr 5.86Cr 36Cr 14Cr 169.56Cr 15Cr 14Cr 619.15Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 113.00 ¥ | -2.65% | 5,02,332 |
| 15/26/15 | 116.08 ¥ | +1.79% | 3,84,040 |
| 14/26/14 | 114.04 ¥ | +0.16% | 6,06,886 |
| 13/26/13 | 113.86 ¥ | +1.68% | 6,72,890 |
| 12/26/12 | 111.98 ¥ | -0.03% | 4,14,441 |
End-of-day quote Shanghai S.E., January 16, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688198 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition